GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B5382 d[Cha4]-AVPSummary: human vasopressin V1B receptor agonist -
B5383 d[Leu4,Lys8]-VPSummary: Selective vasopressin V1B receptor agonist -
B5388 [Orn5]-URPSummary: Urotensin-II (UT) receptor pure antagonist -
B5394 Lys-[Des-Arg9]BradykininSummary: bradykinin B1 receptor agonist -
B5395 R 892Summary: bradykinin B1 receptor antagonist -
B5396 Lys-BradykininSummary: Endogenous bradykinin receptor agonist -
B5397 [Lys5,MeLeu9,Nle10]-NKA(4-10)Summary: Highy selective and potent NK2 receptor agonist -
B5398 [Phe8Ψ(CH-NH)-Arg9]-BradykininSummary: Selective bradykinin B2 receptor agonist -
B5399 Sar-[D-Phe8]-des-Arg9-BradykininSummary: selective bradykinin B1 receptor agonist -
B5400 Ac9-25Summary: formyl peptide receptor 1 (FPR1) ligand

